Clinical Trial Update: Zinc and Pneumonia Protocol [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating zinc for pneumonia and acute respiratory infections was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumonia
• Respiratory Infection

Drugs mentioned

• ZINC (Zinc chloride)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Respiratory Infections, Acute | Phase 3 | Status: TERMINATED